Open access
Open access
Powered by Google Translator Translator

Infectious Diseases (all articles)

Editorial: What went wrong in the global governance of covid-19?

7 Feb, 2021 | 21:27h | UTC

What went wrong in the global governance of covid-19? – The BMJ

Related: The Five Things to Get Right Before the Next Pandemic – Bloomberg AND International collaboration and covid-19: what are we doing and where are we going? – The BMJ AND Why did the world’s pandemic warning system fail when COVID hit? – Nature AND One Year Later: COVID-19 Versus WHO And The World – Successes, Failures & Hopes – Health Policy Watch AND WHO’s Covid warnings were not heeded. Now the world has a new chance to beat the virus – The Guardian

 


The good and the (potentially) bad: What scientists know about variants and Covid-19 vaccines

7 Feb, 2021 | 21:23h | UTC

The good and the (potentially) bad: What scientists know about variants and Covid-19 vaccines – STAT

See also: What Will it Take to Make Covid-19 Vaccines Variant-Proof? – Wired AND What’s Going On With All These Coronavirus Variants? An Illustrated Guide – NPR AND Video: Coronavirus Variants – What They Mean – JAMA

 


SR/MA: ICU mortality from COVID-19 continued to fall in 2020, but improvement is slowing

7 Feb, 2021 | 21:18h | UTC

News release: ICU mortality from COVID-19 continued to fall in 2020, but improvement is slowing – University of Bristol

Original article: Mortality in patients admitted to intensive care with COVID‐19: an updated systematic review and meta‐analysis of observational studies – Anaesthesia

 

Commentary on Twitter

 


Cohort study: ECMO in patients with severe respiratory failure from COVID-19

7 Feb, 2021 | 21:16h | UTC

Extracorporeal membrane oxygenation in patients with severe respiratory failure from COVID-19 – Intensive Care Medicine

Related: ECMO for COVID-19 patients in Europe and Israel – Intensive Care Medicine

 

Commentaries on Twitter

 


What’s the risk of dying from a fast-spreading COVID-19 variant?

7 Feb, 2021 | 21:21h | UTC

What’s the risk of dying from a fast-spreading COVID-19 variant? – Nature

Original study: Increased hazard of death in community-tested cases of SARS-CoV-2 Variant of Concern 202012/01 – medRxiv

 


Review: “Silent” Presentation of Hypoxemia and Cardiorespiratory Compensation in COVID-19

7 Feb, 2021 | 21:13h | UTC

“Silent” Presentation of Hypoxemia and Cardiorespiratory Compensation in COVID-19 – Anesthesia

 


Report: The state of the world’s antibiotics report in 2021

7 Feb, 2021 | 20:49h | UTC

The State of the World’s Antibiotics Report in 2021 – The Center For Disease Dynamics, Economics & Policy

Commentary: Report highlights lack of progress against antimicrobial resistance – CIDRAP

 


SR/MA: Colistin nephrotoxicity

5 Feb, 2021 | 01:21h | UTC

Colistin Nephrotoxicity: Meta-analysis of Randomized Controlled Trials – Open Forum Infectious Diseases

 


Opinion: Vaccine Nationalism Harms Everyone and Protects No One

5 Feb, 2021 | 01:45h | UTC

Vaccine Nationalism Harms Everyone and Protects No One – Foreign Policy

Related: Jeremy Farrar: Until we are all safe, no one is safe. Covid is a global problem – The Guardian AND Covid-19: WHO warns against “vaccine nationalism” or face further virus mutations – The BMJ AND ‘Vaccine nationalism’ threatens global plan to distribute COVID-19 shots fairly – Science AND WHO chief warns against ‘catastrophic moral failure’ in COVID-19 vaccine access – United Nations

 


NIH Treatment Guideline Update: “there are insufficient data to recommend either for or against the use of tocilizumab or sarilumab for the treatment of COVID-19”

5 Feb, 2021 | 01:44h | UTC

The COVID-19 Treatment Guidelines Panel’s Statement on the Use of Tocilizumab (and Other Interleukin-6 Inhibitors) for the Treatment of COVID-19 – National Institutes of Health

 


Study: Adults between 20 and 49 years responsible for most Covid-19 spread

5 Feb, 2021 | 01:43h | UTC

Age groups that sustain resurging COVID-19 epidemics in the United States – Science

Commentaries: Adults 20 to 49 may have driven 72% of US COVID-19 surges – CIDRAP AND Younger adults responsible for most of COVID-19 spread: Study – ABC News

 


Study: Single dose Pfizer Covid-19 vaccine effectiveness estimated at 90% after 21 days

5 Feb, 2021 | 01:43h | UTC

Estimating the effectiveness of the Pfizer COVID-19 BNT162b2 vaccine after a single dose. A reanalysis of a study of ‘real-world’ vaccination outcomes from Israel. – medRxiv

Commentaries: One Pfizer/BioNTech jab gives ‘90% immunity’ from Covid after 21 days – The Guardian AND Expert reaction to preprint reanalysing study of real-world Pfizer vaccination outcomes after one dose from Israel – Science Media Centre

 

Commentary on Twitter

 


Phase 1/2 Clinical Trial: CoronaVac is safe and well tolerated in older adults. Neutralizing antibodies were detected in over 90% of participants in all groups

5 Feb, 2021 | 01:41h | UTC

Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy adults aged 60 years and older: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial – The Lancet Infectious Diseases

Commentary: Inactivated COVID-19 vaccines to make a global impact – The Lancet Infectious Diseases

 

Commentary on Twitter

https://twitter.com/hildabast/status/1357281190198140929

 


New COVID-19 vaccines: here’s how the promising Novavax and Johnson & Johnson jabs work

5 Feb, 2021 | 01:41h | UTC

New COVID-19 vaccines: here’s how the promising Novavax and Johnson & Johnson jabs work – The Conversation

 


Dialysis patients have 4-fold greater risk of dying from COVID-19

5 Feb, 2021 | 01:39h | UTC

News Release: Dialysis patients have 4-fold greater risk of dying from COVID-19 – Canadian Medical Association Journal

Original Study: COVID-19 in patients undergoing long-term dialysis in Ontario – Canadian Medical Association Journal

 


Why the WHO won’t call it the ‘U.K. variant’, and you shouldn’t either

5 Feb, 2021 | 01:40h | UTC

Why the WHO won’t call it the ‘U.K. variant’, and you shouldn’t either – CTV News

Related: The world needs a single naming system for coronavirus variants – Nature

 


Policy Statement: Antibiotic Stewardship in Pediatrics

4 Feb, 2021 | 01:21h | UTC

Antibiotic Stewardship in Pediatrics – Pediatrics

Commentary: Guidance Provided for Antibiotic Stewardship in Pediatrics

 


WHO: Consecutive drop in new COVID-19 cases ‘encouraging news’

4 Feb, 2021 | 01:37h | UTC

Consecutive drop in new COVID-19 cases ‘encouraging news’: WHO – UN News

 


UK Biobank study shows that COVID-19 antibodies remain for at least 6 months post-infection for the vast majority of people who have had the virus

4 Feb, 2021 | 01:32h | UTC

UK Biobank study shows that COVID-19 antibodies remain for at least 6 months post-infection for the vast majority of people who have had the virus – Biobank

Commentary: Covid: Antibodies last at least six months in most – BBC

 


RECOVERY trial: Azithromycin not beneficial for patients admitted to hospital with COVID-19

4 Feb, 2021 | 01:39h | UTC

Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial – The Lancet

Invited Commentary: Azithromycin, RECOVERY, and the power of large, simple trials – The Lancet

 


Study shows the viral load of index cases is a leading driver of SARS-CoV-2 transmission

4 Feb, 2021 | 01:35h | UTC

Transmission of COVID-19 in 282 clusters in Catalonia, Spain: a cohort study – The Lancet Infectious Diseases

Commentary: Understanding the drivers of transmission of SARS-CoV-2 – The Lancet Infectious Diseases

 


Racing the virus: Why tweaking vaccines to fight variants won’t be simple

4 Feb, 2021 | 01:28h | UTC

Racing the virus: Why tweaking vaccines to fight variants won’t be simple – Reuters

 


Video (3 min): Sinovac and Sinopharm – what do we know about the Chinese vaccines?

4 Feb, 2021 | 01:31h | UTC

Sinovac and Sinopharm – what do we know about the Chinese vaccines? – BBC

 


[Preprint] Meta-analysis: More than 50 Long-term effects of COVID-19

4 Feb, 2021 | 01:26h | UTC

More than 50 Long-term effects of COVID-19: a systematic review and meta-analysis – medRxiv

Commentary: 80% of COVID-19 Patients May Have Lingering Symptoms, Signs — More than 50 effects persisted after acute infection, meta-analysis shows – MedPage Today (free registration required)

 


The COVID-19 vaccine in pregnancy: risks, benefits, and recommendations

4 Feb, 2021 | 01:30h | UTC

The COVID-19 vaccine in pregnancy: risks benefits and recommendations – American Journal of Obstetrics and Gynecology

Related: Pregnancy, breastfeeding and the SARS-CoV-2 vaccine: an ethics-based framework for shared decision-making AND The Coronavirus Vaccine Presents a Dilemma for Pregnant Women – The New Yorker

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.